title: The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.
abstract: There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.
authors.forename: Paulus
authors.initials: P
authors.lastname: Kirchhof
authors.forename: Karin R
authors.initials: KR
authors.lastname: Sipido
authors.forename: Martin R
authors.initials: MR
authors.lastname: Cowie
authors.forename: Thomas
authors.initials: T
authors.lastname: Eschenhagen
authors.forename: Keith A A
authors.initials: KA
authors.lastname: Fox
authors.forename: Hugo
authors.initials: H
authors.lastname: Katus
authors.forename: Stefan
authors.initials: S
authors.lastname: Schroeder
authors.forename: Heribert
authors.initials: H
authors.lastname: Schunkert
authors.forename: Silvia
authors.initials: S
authors.lastname: Priori
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000379:methods; D003952:Diagnostic Imaging; D004059:Diffusion of Innovation; D019317:Evidence-Based Medicine; D023281:Genomics; D006801:Humans; D020380:Needs Assessment; D018802:Patient-Centered Care / Q000379:methods; D057285:Precision Medicine; D018570:Risk Assessment
chemical_list: D015415:Biomarkers